CEVA employs 200 people worldwide, with research and development facilities in Israel and Ireland and sales and support offices in Hong Kong, China, Taiwan, Korea, Japan, Sweden, Israel, and the United States. CEVA is traded on the NASDAQ stock exchange (NASDAQ:CEVA).